Nektar Therapeutics (NKTR)
$22.31
0.07 (0.31%)
19:08 EST
NKTR Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
3.82B
PE Ratio
-27.89
EPS
-0.8
Volume (Avg. Vol.)
1.29M
Day's Range
20.84 - 22.49
52-Week Range
13.63 - 26.75
Dividend & Yield
N/A (N/A)
NKTR Stock Predictions, Articles, and Nektar Therapeutics News
- From InvestorPlace
- From the Web
7 Big Biotech Stocks to Avoid
The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.
7 Worst Stocks in the S&P 500 in 2019
While the markets have roared higher in 2019, these stocks have been crashing. But some of them could rebound soon.
8 Biotech Stocks to Watch After the Q2 Earnings Season
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
10 Oversold Stocks to Run From
Wells Fargo, HP and Gilead Sciences are just three oversold stocks to sell before they lose any more ground.
9 U.S. Stocks That Are Coming to Life Again
All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.
7 Biotech Stocks to Buy Now
Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.
3 Big Stock Charts for Friday: Nektar Therapeutics, Waters and A.O. Smith
As we move into the weekend, the stock charts of AOS, NKTR and WAT should be on your radar.
5 Big Pharma Stocks Investors Love Right Now
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd.
Nektar Therapeutics Stock Is a Buy After a Major Market Misread
Sellers dominated the trading action on Nektar stock after its preliminary clinical results. Over-reaction or justified selling? The market simply did not understand the results, hurting the NKTR stock price.
Why Bristol-Myers Squibb Company Shares Are Down Today
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors.
Why Nektar Therapeutics Shares Are Plunging Today
Nektar Therapeutics (NKTR) took a heavy hit on Monday following the release of preliminary results from a recent clinical trial.
Nektar Therapeutics Stock Is Risky But Offers Big Reward
Nektar Therapeutics pulled back in recent weeks, and that is a good thing. Valuations are stretched, but the upside in NKTR stock is high if management delivers.
3 Stocks to Watch on Friday: Alphabet Inc (GOOG, GOOGL), Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG)
Alphabet Inc (GOOG,GOOGL) is fixing latency issues with Google Home Max, while Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG) reported earnings.
7 A-Rated Healthcare Stocks to Buy
It may be all about taxes now, but 2018 is all about healthcare. The following are some of the best healthcare stocks to buy in 2018.
Stocks Weak Amid Fed Hawkishness on Rate Hikes
In the end, the Dow lost a fraction, the S&P gave back 0.2%, the Nasdaq gained a fraction and the Russell 2000 finished the day 0.5% lower.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
16 Pharmaceuticals Stocks to Sell Now
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
13 Pharmaceuticals Stocks to Sell Now
The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – BSPM RTTR SCL CCXI
The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
Sell